Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IDNA vs SWHFX overlap: 18% of top holdings shared

Bottom line

How much do IDNA and SWHFX overlap?

18% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 26.8% of IDNA's assets and 14.9% of SWHFX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

IDNASWHFX
Weight overlap (top 25)18%
Shared holdings7
Weight in shared holdings26.8%14.9%
Total positions6180
Expense ratio0.47%0.8%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings IDNA and SWHFX have in common

Holding% of IDNA% of SWHFXOverlap
Incyte Corporation4.23%1.37%1.37%
Merck & Co., Inc.3.91%4.98%3.91%
Vertex Pharmaceuticals Incorporated3.87%1.89%1.89%
Roche Holding AG3.85%2.29%2.29%
Ipsen Sa3.84%1.34%1.34%
Gsk Plc3.63%1.73%1.73%
Sanofi Sa3.46%1.31%1.31%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IDNA

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Moderna, Inc. — 4.19%
  8. Takeda Pharmaceutical Company Limited — 4.05%
  9. BioNTech SE — 3.73%
  10. Exelixis, Inc. — 3.65%
  11. IDEAYA Biosciences Inc — 3.36%
  12. Immunitybio Inc — 3.07%
  13. Arcus Biosciences, Inc. — 2.68%
  14. Caris Life Sciences, Inc. — 2.19%
  15. Ono Pharmaceutical Co., Ltd. — 1.91%

Only in SWHFX

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. UnitedHealth Group Inc — 4.74%
  5. Gilead Sciences Inc — 3.24%
  6. Novartis AG — 2.92%
  7. Amgen Inc — 2.58%
  8. Bristol-Myers Squibb Co — 2.44%
  9. Medtronic PLC — 2.29%
  10. Thermo Fisher Scientific Inc — 2.16%
  11. Stryker Corp — 2.11%
  12. Boston Scientific Corp — 1.60%
  13. Abbott Laboratories — 1.60%
  14. Cigna Group/The — 1.51%
  15. Danaher Corp — 1.47%

Asset mix

Asset typeIDNASWHFX
Stocks96.0%99.0%
Cash & short-term funds10.5%—
Other3.8%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryIDNASWHFX
US70.2%78.6%
DE8.5%—
FR7.8%2.6%
JP6.0%2.3%
CH5.4%5.2%
IE—4.5%
DK4.2%0.7%
GB3.7%3.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do IDNA and SWHFX overlap?
About 18% by weight. 7 securities appear in both funds' top 25 holdings; they make up 26.8% of IDNA's assets and 14.9% of SWHFX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IDNA and SWHFX have in common?
The largest shared holdings are Merck & Co., Inc., Roche Holding AG, Vertex Pharmaceuticals Incorporated, Gsk Plc, Incyte Corporation.
Should I own both IDNA and SWHFX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IDNA or SWHFX?
SWHFX is broader, with 80 positions versus 61 for IDNA. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.